Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct - a Randomized Double-blind Controlled Trial

NCT04122300 is registered in ClinicalTrials.gov with University of Bern as lead sponsor.

NCT NCT04122300
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04122300 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct - a Randomized Double-blind Controlled Trial
Lead sponsor
University of Bern
Phase
Phase 3
Overall status
Completed
Start date
May 22, 2011
Completion date
December 16, 2016
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

congenita nasolacrimal duct obstruction, ocular discharge, preterm neonates